Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-04-11
2006-04-11
Dentz, Bernard (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C544S302000, C548S187000
Reexamination Certificate
active
07026491
ABSTRACT:
Novel compounds composition capable of inhibiting TNFα and having antiimmunoinflammatory and autoimmune properties useful in a pharmaceutical composition, such as for a drug containing this as an active ingredient; and a therapeutic method with the use of these novel compounds.
REFERENCES:
patent: 3259635 (1966-07-01), Ritter et al.
patent: 522 631 (1972-06-01), None
patent: 0 171 645 (1986-02-01), None
patent: 0 428 939 (1991-05-01), None
patent: WO 92 11383 (1992-07-01), None
patent: WO 99 15523 (1999-04-01), None
Beutler, et al., Science, Oct. 1986, 470-474, vol. 234.
Grilli, et al., International Review of Cytology, (1993), 1-63, vol. 143.
Pisetsky, The New England Journal of Medicine, Mar. 2000, 810-811,vol. 342, No. 11.
Shohami et al., Journal of Cerebral Blood Flow and Metabolism, (1994), 615-619, vol. 14, No. 4.
Van Dullemen, et al., Gastroenterology (1995), 129-135, vol. 109, No. 1.
Arrhenius Thomas
Chen Mi
Cheng Jie Fei
Kashiwagi Hirotaka
Ono Yoshiyuki
Chugai Seiyaku Kabushiki Kaisha
Dentz Bernard
LandOfFree
Coumarin derivatives useful as TNFα inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Coumarin derivatives useful as TNFα inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coumarin derivatives useful as TNFα inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3557119